Rosamaria Orlando

Dr. Rosamaria Orlando

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Neuropharmacology
Verified
Journal Article
Open access
LMLuisa Di Menna
Luisa Di Menna
MJMax Joffe
Max Joffe
LILuisa Iacovelli
Luisa Iacovelli
RORosamaria Orlando
Rosamaria Orlando
CLCraig W. Lindsley
Craig W. Lindsley
Ferdinando NicolettiFerdinando Nicoletti
Ferdinando Nicoletti
MGlu5 receptors are involved in mechanisms of activity-dependent synaptic plasticity, and are targeted by drugs developed for the treatment of CNS disorders. We report that mGlu3 receptors, which are traditionally linked to the control of neurotransmitter release, support mGlu5 receptor signaling in neurons and largely contribute to the robust mGlu5 receptor-mediated polyphosphoinositide hydrolysis in the early postnatal life. In cortical pyramidal neurons, mGlu3 receptor activation potentiated mGlu5 receptor-mediated somatic Ca2+ mobilization, and mGlu3 receptor-mediated long-term depression in the prefrontal cortex required the endogenous activation of mGlu5 receptors. The interaction between mGlu3 and mGlu5 receptors was also relevant to mechanisms of neuronal toxicity, with mGlu3 receptors shaping the influence of mGlu5 receptors on excitotoxic neuronal death. These findings shed new light into the complex role played by mGlu receptors in physiology and pathology, and suggest reconsideration of some of the current dogmas in the mGlu receptor field.

1 June 2018 in Pharmacological Research
Verified
Journal Article
Closed access
ACAlessandra Caruso
Alessandra Caruso
FNFerdinando Nicoletti
Ferdinando Nicoletti
DMDalila Mango
Dalila Mango
ASAmira Saidi
Amira Saidi
RORosamaria Orlando
Rosamaria Orlando
SSScaccianoce Sergio
Scaccianoce Sergio

1 January 2008 in Platelets
Verified
Journal Article
Closed access
ATAnna Rita Togna
Anna Rita Togna
Valentina LatinaValentina Latina
Valentina Latina
RORosamaria Orlando
Rosamaria Orlando
GTGiuseppina I. Togna
Giuseppina I. Togna
Cigarette smoking is a recognized risk factor for cardiovascular diseases and has been implicated in the pathogenesis of atherosclerosis and thrombotic events. In athero-thrombotic diseases, the extracellular adenine nucleotides play an important role by triggering a range of effects such as the recruitment and activation of platelets, endothelial cell activation and vasoconstriction. NTPDase, a plasma membrane-bound enzyme, is the most relevant enzyme involved in the hydrolysis of extracellular tri- and di-phosphate nucleotides to adenosine monophosphate, which is further degraded by 5'ectonucleotidase to the anti-thrombotic and anti-inflammatory mediator adenosine. Thus, the preserved activity of these enzymes, regulating the extracellular concentrations of nucleotides, is critical in thromboregulatory functions. In the present in vitro study, performed on human platelets suspended in undiluted or diluted aqueous cigarette smoke extract (aCSE), we demonstrated that undiluted and 1 : 2 diluted aCSE is able to significantly reduce ADP hydrolysis (-24% and 12%, respectively) by intact human platelets. ATP degradation was also reduced (-31%) by undiluted aCSE. Conversely, aCSE did not alter platelet AMP hydrolysis. Results obtained by using N-acetylcysteine, a thiol-containing antioxidant, suggest that stable oxidants present in aCSE are responsible for the platelet NTPDase inhibition induced by aCSE. The decreased adenine nucleotide degradation could play a significant role in the extensive platelet activation and vascular inflammation observed in chronic smokers.

1 February 2018 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
LILuisa Iacovelli
Luisa Iacovelli
RORosamaria Orlando
Rosamaria Orlando
ARAlessandro Rossi
Alessandro Rossi
PSPaola Spinsanti
Paola Spinsanti
DMDaniela Melchiorri
Daniela Melchiorri
FNFerdinando Nicoletti
Ferdinando Nicoletti

21 March 2022 in Life
Verified
Journal Article
Open access
PDF file
ATAna Elena Teleuca
Ana Elena Teleuca
GAGiovanni Sebastiano Alemà
Giovanni Sebastiano Alemà
PCPaola Casolini
Paola Casolini
IBIlaria Barberis
Ilaria Barberis
FCFrancesco Ciabattoni
Francesco Ciabattoni
AZAnna Rita Zuena
Anna Rita Zuena
Using an in vivo method for the assessment of polyphosphoinositide (PI) hydrolysis, we examine whether spatial learning and memory extinction cause changes in mGlu5 metabotropic glutamate receptor signaling in the hippocampus and prefrontal cortex. We use the following five groups of mice: (i) naive mice; (ii) control mice exposed to the same environment as learner mice; (iii) leaner mice, trained for four days in a water maze; (iv) mice in which memory extinction was induced by six trials without the platform; (v) mice that spontaneously lost memory. The mGlu5 receptor-mediated PI hydrolysis was significantly reduced in the dorsal hippocampus of learner mice as compared to naive and control mice. The mGlu5 receptor signaling was also reduced in the ventral hippocampus and prefrontal cortex of learner mice, but only with respect to naive mice. Memory extinction was associated with a large up-regulation of mGlu5 receptor-mediated PI hydrolysis in the three brain regions and with increases in mGlu5 receptor and phospholipase-Cβ protein levels in the ventral and dorsal hippocampus, respectively. These findings support a role for mGlu5 receptors in mechanisms underlying spatial learning and suggest that mGlu5 receptors are candidate drug targets for disorders in which cognitive functions are impaired or aversive memories are inappropriately retained.

1 February 2017 in Neuropharmacology
Verified
Journal Article
Closed access
LILuisa Iacovelli
Luisa Iacovelli
LMLuisa Di Menna
Luisa Di Menna
DPDaniel Peterlik
Daniel Peterlik
CSChristina Stangl
Christina Stangl
RORosamaria Orlando
Rosamaria Orlando
Ferdinando NicolettiFerdinando Nicoletti
Ferdinando Nicoletti